These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2194456)

  • 21. A new member of the troponin C superfamily: comparison of the primary structures of rat oncomodulin and rat parvalbumin.
    MacManus JP; Watson DC; Yaguchi M
    Biosci Rep; 1983 Nov; 3(11):1071-5. PubMed ID: 6661520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation, localization, and properties of the oncodevelopmental calcium-binding protein oncomodulin.
    MacManus JP; Brewer LM
    Methods Enzymol; 1987; 139():156-68. PubMed ID: 3108624
    [No Abstract]   [Full Text] [Related]  

  • 23. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells.
    Yin Y; Henzl MT; Lorber B; Nakazawa T; Thomas TT; Jiang F; Langer R; Benowitz LI
    Nat Neurosci; 2006 Jun; 9(6):843-52. PubMed ID: 16699509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eu3+ luminescence studies of oncomodulin. The origin of the pH-dependent behavior.
    Treviño CL; Palmisano WA; Birnbaum ER; Henzl MT
    J Biol Chem; 1990 Jun; 265(17):9694-700. PubMed ID: 2351666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lanthanide-binding properties of rat oncomodulin.
    Henzl MT; Hapak RC; Birnbaum ER
    Biochim Biophys Acta; 1986 Jul; 872(1-2):16-23. PubMed ID: 3730394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma oncomodulin is proportional to tumour burden in rats bearing Morris hepatomas 5123D, 5123tc, 7288 and 7777.
    MacManus JP
    Tumour Biol; 1984; 5(3-4):189-97. PubMed ID: 6505549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The LTR promoter of the rat oncomodulin gene is regulated by cell-line specific accessibility in the LTR U3 region.
    Rentsch JM; Hergersberg M; Banville D; Berchtold MW
    Arch Biochem Biophys; 2006 Mar; 447(1):68-79. PubMed ID: 16469291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refinement of recombinant oncomodulin at 1.30 A resolution.
    Ahmed FR; Rose DR; Evans SV; Pippy ME; To R
    J Mol Biol; 1993 Apr; 230(4):1216-24. PubMed ID: 8487302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
    Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S
    Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varying oncomodulin mRNA abundance in developing placenta and solid tumors.
    Gillen MF; Brewer LM; MacManus JP
    Cancer Lett; 1988 Jun; 40(2):151-60. PubMed ID: 3383173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The differential stimulation of brain and heart cyclic-AMP phosphodiesterase by oncomodulin.
    Mutus B; Karuppiah N; Sharma RK; MacManus JP
    Biochem Biophys Res Commun; 1985 Aug; 131(1):500-6. PubMed ID: 2994666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calmodulin-like effect of oncomodulin on cell proliferation.
    Blum JK; Berchtold MW
    J Cell Physiol; 1994 Sep; 160(3):455-62. PubMed ID: 8077283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncomodulin affords limited regeneration to injured sensory axons in vitro and in vivo.
    Harel R; Iannotti CA; Hoh D; Clark M; Silver J; Steinmetz MP
    Exp Neurol; 2012 Feb; 233(2):708-16. PubMed ID: 22078758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new intrinsic fluorescent probe for proteins. Biosynthetic incorporation of 5-hydroxytryptophan into oncomodulin.
    Hogue CW; Rasquinha I; Szabo AG; MacManus JP
    FEBS Lett; 1992 Oct; 310(3):269-72. PubMed ID: 1383030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo.
    Guerreiro Da Silva ID; Hu YF; Russo IH; Ao X; Salicioni AM; Yang X; Russo J
    Int J Oncol; 2000 Feb; 16(2):231-40. PubMed ID: 10639564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3 peptide recognized by cytotoxic T lymphocytes.
    Takaki T; Hiraki A; Uenaka A; Gomi S; Itoh K; Udono H; Shibuya A; Tsuji T; Sekiguchi S; Nakayama E
    Int J Oncol; 1998 May; 12(5):1103-9. PubMed ID: 9538136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective and axon growth promoting effects of intraocular inflammation do not depend on oncomodulin or the presence of large numbers of activated macrophages.
    Hauk TG; Müller A; Lee J; Schwendener R; Fischer D
    Exp Neurol; 2008 Feb; 209(2):469-82. PubMed ID: 18021771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
    Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
    Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells.
    Rawson P; Hermans IF; Huck SP; Roberts JM; Pircher H; Ronchese F
    Cancer Res; 2000 Aug; 60(16):4493-8. PubMed ID: 10969797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.
    Valmori D; Fonteneau JF; Lizana CM; Gervois N; Liénard D; Rimoldi D; Jongeneel V; Jotereau F; Cerottini JC; Romero P
    J Immunol; 1998 Feb; 160(4):1750-8. PubMed ID: 9469433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.